Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
NNOX 
Nano X Imaging Ltd (NNOX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: NNOX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $7.75
1 Year Target Price $7.75
| 4 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -13.76% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/16/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 250.00M USD | Price to earnings Ratio - | 1Y Target Price 7.75 |
Price to earnings Ratio - | 1Y Target Price 7.75 | ||
Volume (30-day avg) 4 | Beta 1.93 | 52 Weeks Range 3.63 - 11.00 | Updated Date 09/16/2025 |
52 Weeks Range 3.63 - 11.00 | Updated Date 09/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.9 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -475.59% |
Management Effectiveness
Return on Assets (TTM) -18.97% | Return on Equity (TTM) -32.87% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 205689216 | Price to Sales(TTM) 21.03 |
Enterprise Value 205689216 | Price to Sales(TTM) 21.03 | ||
Enterprise Value to Revenue 17.31 | Enterprise Value to EBITDA -7.41 | Shares Outstanding 63939600 | Shares Floating 61156328 |
Shares Outstanding 63939600 | Shares Floating 61156328 | ||
Percent Insiders 0.23 | Percent Institutions 20.87 |
Upturn AI SWOT
Nano X Imaging Ltd
Company Overview
History and Background
Nano X Imaging Ltd. (Nanox) was founded in 2012. Its mission is to democratize medical imaging through the development of a cost-effective digital X-ray source. The company has faced scrutiny regarding its technology and business model but continues to pursue regulatory approvals and commercialization.
Core Business Areas
- Medical Imaging Systems: Development, manufacturing, and deployment of the Nanox.ARC, a multi-source digital X-ray device. Also includes the Nanox.CLOUD, a cloud-based service for image storage, reporting, and AI analysis.
- Services and Software: Provision of medical imaging services using the Nanox.ARC and related software applications. Includes pay-per-scan services and diagnostic support tools.
Leadership and Structure
The company is led by Erez Meltzer, CEO. The organizational structure includes departments for research and development, operations, commercialization, and finance.
Top Products and Market Share
Key Offerings
- Nanox.ARC: A digital X-ray device that uses a microelectromechanical systems (MEMS) based X-ray source. Claims to offer lower cost and improved accessibility compared to traditional X-ray machines. Market share is currently near zero due to limited commercial deployments, revenue is immaterial. Competitors are GE Healthcare (GE), Siemens Healthineers (SIEGY), Philips (PHG).
- Nanox.CLOUD: A cloud-based platform for image storage, analysis, and reporting. Designed to integrate with the Nanox.ARC and other imaging devices. Market share is currently near zero as it needs to be used with Nanox.ARC. Competitors are multiple large healthcare IT players.
Market Dynamics
Industry Overview
The medical imaging market is a large and established industry dominated by large players. It is characterized by high barriers to entry due to regulatory requirements and technological complexity. The market is driven by aging populations, increasing demand for diagnostic imaging, and technological advancements.
Positioning
Nanox aims to disrupt the medical imaging market by offering a lower-cost and more accessible alternative to traditional X-ray systems. Its competitive advantage is based on its MEMS-based X-ray source technology.
Total Addressable Market (TAM)
The global medical imaging market is expected to reach hundreds of billions of dollars. Nanox aims to capture a portion of this market by focusing on underserved areas and offering a more affordable solution. The TAM is significant but Nanox needs to be compliant with all regulations.
Upturn SWOT Analysis
Strengths
- Novel X-ray technology (MEMS-based source)
- Potential for lower cost compared to traditional X-ray
- Cloud-based service platform
- Focus on underserved markets
Weaknesses
- Limited commercial deployments
- Past controversies regarding technology claims
- Dependence on regulatory approvals
- Significant ongoing losses and high cash burn
Opportunities
- Expanding access to medical imaging in developing countries
- Partnerships with healthcare providers and distributors
- Development of new applications for its technology
- Integration of AI-powered diagnostic tools
Threats
- Competition from established medical imaging companies
- Technological obsolescence
- Regulatory hurdles and delays
- Negative publicity and reputational risks
Competitors and Market Share
Key Competitors
- GE
- SIEGY
- PHG
Competitive Landscape
Nanox faces intense competition from established players with extensive resources and regulatory expertise. Nanox's advantage lies in its innovative technology and potential for lower costs, but it needs to overcome regulatory hurdles and build trust with healthcare providers.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is limited due to the early stage of commercialization and regulatory delays.
Future Projections: Future growth depends on regulatory approvals, successful commercialization of the Nanox.ARC, and adoption of its cloud platform. Analyst estimates vary widely due to the uncertainty surrounding the company's prospects.
Recent Initiatives: Recent initiatives include seeking regulatory approvals in various countries, expanding its manufacturing capabilities, and forging partnerships with healthcare providers.
Summary
Nanox is a high-risk, high-reward company attempting to disrupt the medical imaging industry. Its innovative technology and focus on underserved markets present significant opportunities, but the company faces significant challenges, including regulatory hurdles, competition from established players, and a history of controversial claims. Nanox needs to successfully commercialize its technology and build a sustainable business model to achieve its long-term goals. It is a company with high promise, but large amounts of regulatory uncertainty.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Press Releases
- Analyst Reports
- Market Research Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. The information provided is based on available data and analyst estimates, which are subject to change. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Nano X Imaging Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2020-08-21 | CEO & Acting Chairman of the Board Mr. Erez I. Meltzer | ||
Sector Healthcare | Industry Medical Devices | Full time employees 165 | Website https://www.nanox.vision |
Full time employees 165 | Website https://www.nanox.vision | ||
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide and obtain remote interpretations of imaging data; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. The company was founded in 2011 and is headquartered in Petah Tikva, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.